section name header

Information

AHFS Class:

10:00 Antineoplastic Agents

Generic Name

Products

Asparaginase Erwinia chrysanthemi is available as a lyophilized powder in vials containing 10,000 international units of the drug.2896 Each vial also contains glucose monohydrate 5 mg and sodium chloride 0.5 mg.2896

Reconstitute each vial with 1 or 2 mL of preservative-free sodium chloride 0.9% to yield solutions of 10,000 or 5000 international units/mL, respectively.2896 Direct the stream of diluent at the vial wall and not directly into the powder.2896 Swirl or gently mix to dissolve the powder; do not shake or invert the vial.2896

Trade Name(s)

Erwinaze

Administration

Asparaginase Erwinia chrysanthemi is administered intramuscularly using a volume no greater than 2 mL; larger volumes require 2 injection sites.2896

Stability

Intact vials and cartons of asparaginase Erwinia chrysanthemi should be stored under refrigeration and protected from light.2896

Asparaginase Erwinia chrysanthemi, a white lyophilized powder, becomes a clear, colorless solution on reconstitution.2896 If any visible particles or protein aggregates are present, the reconstituted solution should be discarded.2896

The volume of the reconstituted solution containing the calculated dose should be withdrawn from the vial into a polypropylene syringe within 15 minutes of reconstitution and administered within 4 hours.2896 The manufacturer indicates that the reconstituted solution should not be stored under refrigeration or frozen.2896 Any unused portions should be discarded.2896

Other Info

References

For a list of references cited in the text of this monograph, search the monograph titled References.

Copyrights

ASHP® Injectable Drug InformationTM. Selected Revisions June 1, 2019. © Copyright, 2025. American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.